Bernstein C N, Kolodny M, Block E, Shanahan F
Department of Medicine, University of California, Los Angeles.
Am J Gastroenterol. 1993 Apr;88(4):574-7.
Today, Pneumocystis carinii pneumonia (PCP) is typically associated with AIDS. However, in the pre-AIDS era, PCP was known to be associated with various immunodeficiency states, malignancies, and immunosuppressive therapy, particularly the use of corticosteroids. PCP has been reported to occur during immuno-suppressive therapy of some chronic inflammatory states, but it has never been reported in patients with inflammatory bowel disease. We report two patients with ulcerative colitis who developed PCP during high-dose corticosteroid therapy, and review the literature regarding non-AIDS PCP. PCP should thus be added to the list of bronchopulmonary complications in inflammatory bowel disease. This report should give gastroenterologists further impetus to limit immunosuppressive therapy to its minimal effective dose.
如今,卡氏肺孢子虫肺炎(PCP)通常与艾滋病相关。然而,在艾滋病流行前的时代,已知PCP与各种免疫缺陷状态、恶性肿瘤以及免疫抑制治疗有关,尤其是皮质类固醇的使用。据报道,PCP在一些慢性炎症状态的免疫抑制治疗期间会发生,但从未在炎症性肠病患者中报道过。我们报告了两名溃疡性结肠炎患者,他们在大剂量皮质类固醇治疗期间发生了PCP,并回顾了关于非艾滋病相关PCP的文献。因此,PCP应被列入炎症性肠病的支气管肺部并发症清单中。本报告应促使胃肠病学家进一步推动将免疫抑制治疗限制在其最小有效剂量。